Related references
Note: Only part of the references are listed.Role and regulation of phosphatidylinositol 3-kinase β in platelet integrin α2β1 signaling
Alessandra Consonni et al.
BLOOD (2012)
Nitric oxide enhances the anti-inflammatory and anti-atherogenic activity of atorvastatin in a mouse model of accelerated atherosclerosis
Stefania Momi et al.
CARDIOVASCULAR RESEARCH (2012)
Early Inflammatory Reactions in Atherosclerosis Are Induced by Proline-Rich Tyrosine Kinase/Reactive Oxygen Species-Mediated Release of Tumor Necrosis Factor-α and Subsequent Activation of the p21Cip1/Ets-1/p300 System
Asako Katsume et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Targeting Pyk2 for therapeutic intervention
Christopher A. Lipinski et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
Cellular functions of FAK kinases: insight into molecular mechanisms and novel functions
Michael D. Schaller
JOURNAL OF CELL SCIENCE (2010)
HIV-1 gp120-induced migration of dendritic cells is regulated by a novel kinase cascade involving Pyk2, p38 MAP kinase, and LSP1
Appakkudal R. Anand et al.
BLOOD (2009)
Loss of matrix metalloproteinase 2 in platelets reduces arterial thrombosis in vivo
Stefania Momi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Protein-tyrosine kinase CAKβ/PYK2 is activated by binding Ca2+/calmodulin to FERM F2 α2 helix and thus forming its dimer
Takayuki Kohno et al.
BIOCHEMICAL JOURNAL (2008)
Potentiation and priming of platelet activation: a potential target for antiplatelet therapy
Paolo Gresele et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2008)
The low-molecular-weight phosphotyrosine phosphatase is a negative regulator of FcγRIIA-mediated cell activation
Francesca Mancini et al.
BLOOD (2007)
NCX 6560, a nitric oxide-releasing derivative of atorvastatin, inhibits cholesterol biosynthesis and shows anti-inflammatory and anti-thrombotic properties
Stefania Momi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Central role of calcium-dependent tyrosine kinase PYK2 in endothelial nitric oxide synthase-mediated angiogenic response and vascular function
Akihiro Matsui et al.
CIRCULATION (2007)
Activation of p38 MAPKinase/cPLA(2) pathway in homocysteine-treated platelets
G Leoncini et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Nongenomic effects of 17 beta-estradiol in human platelets: potentiation of thrombin-induced aggregation through estrogen receptor and Src kinase
L Moro et al.
BLOOD (2005)
Focal adhesion kinase-related protein tyrosine kinase Pyk2 in T-cell activation and function
HL Ostergaard et al.
IMMUNOLOGIC RESEARCH (2005)
Role of the Pyk2-MAP kinase-cPLA2 signaling pathway in shear-dependent platelet aggregation
L Sun et al.
ANNALS OF BIOMEDICAL ENGINEERING (2004)
Regulatory mechanism and physiological role of cytosolic phospholipase A2
T Hirabayashi et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2004)
Contribution of protease-activated receptors 1 and 4 and glycoprotein Ib-IX-V in the Gi-independent activation of platelet Rap1B by thrombin
P Lova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Pyk2 regulates multiple signaling events crucial for macrophage morphology and migration
M Okigaki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Phosphoinositide 3-kinase-γ induces Xenopus oocyte maturation via lipid kinase activity
S Hehl et al.
BIOCHEMICAL JOURNAL (2001)
RAFTK/Pyk2 involvement in platelet activation is mediated by phosphoinositide 3-kinase
K Koziak et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Involvement of proline-rich tyrosine kinase 2 in platelet activation:: tyrosine phosphorylation mostly dependent on αIIbβ3 integrin and protein kinase C, translocation to the cytoskeleton and association with Shc through Grb2
T Ohmori et al.
BIOCHEMICAL JOURNAL (2000)
RAFTK/Pyk2-mediated cellular signalling
H Avraham et al.
CELLULAR SIGNALLING (2000)